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HR ¼ 0.947, p ¼ 0.849 and amputation HR ¼ 0.971, p ¼ 0.906). All trends
were lost in diabetic patients alone (n ¼ 149, 69% of group).
Conclusion: In this the largest series of combined angioplasty in the
literature there was no advantage in opening up all the tibial vessels with
angioplasty if the angiosome directly supplying the ischaemic tissue could
be opened. The angiosome model does not appear valid, however, in
diabetic patients.
Long Term Risk for Peripheral Arterial Disease Patients is Higher
Among Men
B. Sigvant
Dept. of Surgery, Central Hospital in Karlstad, Sweden
Introduction: The introduction of modern cardiovascular risk preventive
therapy and new endovascular treatment options may have inﬂuenced the
long term mortality and morbidity in patients with peripheral arterial dis-
ease (PAD). The aim of this study was to determine long-term survival and
incidence of leg revascularizations in subjects with PAD with special focus
on gender differences.
Methods: A cohort study was started 2004 by randomly selecting 8000
subjects, aged 59e89 years, from the population. A total of 5080 subjects
participated and underwent ankle brachial index measurements (ABI). Data
was also collected for risk factors and concomitant diseases. The cohort
was re-examined 2015 covering data from national governmental registries
on survival and surgical interventions for PAD.
Results: The point-prevalence of PAD in 2004 was 11 % (95% CI, 9e13)
for subjects having only asymptomatic PAD (APAD), 7% (6.5 e7) for
intermittent claudication (IC) and 1.2 % (1 e1.5) for those with severe limb
ischemia(SLI). Among the 4926 subjects who were available for follow up at
10 years the mortality rates were 50% for APAD, 59% for IC and 72% for SLI.
Subjects without PAD had a rate of 24%. Mortality was higher among men
(age adjusted 35.9% 95% CI: 34.2e37.6) than women (26.1% 95% CI: 24.7e
27.6) likewise in PAD subjects with diabetes mellitus (68% vs. 52% without,
p < 0.001). Factors signiﬁcantly related to increased mortality were for
men and women, respectively; SLI (HR 1.87 and 1.87), congestive heart
failure (HR 1.69 vs. 2.44), renal failure (HR 1.4. vs. 2.2) and diabetes (HR
1.51 vs. 1.65). Fifty one subjects underwent revascularization because of
chronic leg ischemia in the cohort during the ten years. In the reference
group the rate was 0.4%, while it was 1.9 % of APAD subjects, 5.8 % of the
IC and 6.2% of the SLI group.
Conclusion: The mortality is still high in patients with PAD, and half of
patients with APAD are dead within 10 years which is comparable with IC
patients. The mortality is higher in men than in women. In a population
based cohort like this, very few patients were revascularized, and surpris-
ingly few patients with IC and SLI are offered vascular surgery. Overall,
more focus on mortality in PAD is needed and there is still a need for in-
formation about vascular surgery to GP’s ofﬁces and awareness among PAD
subjects.
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Introduction: Vascular access is used as a lifeline for hemodialysis in pa-
tients with end stage renal disease failure (ESRD). Failure of arteriovenous
ﬁstula (AVF) maturation is still high. The purpose of this study was to
research the effects of clopidogrel in combination with oral iloprost, a
synthetic analog of prostacyclin PGI2.
Methods: Ninety-six diabetic ESRD patients were divided into two
groups. In the ﬁrst group (Group 1, N ¼ 50), clopidogrel (75 mg daily dose)
and an oral prostacycline analog (200 mg daily dose) were administered. In
the second group (Group 2, N ¼ 46), placebo was given. All patients were
taking study medication 7e10 days prior to surgery. A Doppler ultraso-
nographic (USG) examination was performed for measurement of arterialand venous diameters, and peak systolic velocity of arterial ﬂow based on
subsequent ﬁstula adequacy. Autogenous AVFs were constructed in fore-
arm as distally as possible in all patients. Both groups were followed-up for
a year.
Results: In the placebo group, early AVF thrombosis was detected in
two patients (4.3%). AVF maturation failure was noted in 14 patients
(30.4%) in placebo group and in four patients (8%) in clopidogrel plus oral
prostacycline analog group in the early post-operative period (P ¼ 0.001).
The mean maturation time was 38  6.5 and 53  12.8 days in study and
placebo groups, respectively (P ¼ 0.023). The mean blood ﬂow was
352  94 mL/min in placebo group and 604  125 mL/min in study group
(P ¼ 0.001). The arterial end diastolic velocity was 116  14 cm/s in study
group and 72  21 cm/s in placebo group (P ¼ 0.036) 1 year after the
surgery.
Conclusion: Our data indicated that clopidogrel and oral prostacycline
analog as a potent arterial dilator seems to be effective and safe for the
prevention of primary AVF failure in hemodialysis patients and decreased
acute and chronic thrombotic events of AVFs.
Radiation Dose of Cone Beam Computed Tomography and
Computed Tomography during EVAR: A Patient and Phantom
Study
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Introduction: The use Cone Beam Computed Tomography (CBCT) enables
the acquisition of 3D images intra-operative. This advantage might reduce
the need of early Computed Tomography Angiography (CTA) follow up (FU)
since technical success is improved. It is however known the CBCT adds a
considerable amount of radiation to the intervention. This study is quan-
tifying the CBCT radiation in comparison to conventional 1 month FU CTA in
order to increase the awareness of the operator in the intra-operative
setting.
Methods: Radiation dose of CBCT (DynaCT, Siemens) and FU CTA of 30
patients was prospectively studied. The CBCT consisted of two different
protocols and was compared with two different CT scanners (Somatom 16
and Flash, Siemens). The FU CTA included three phases. Conversion factors
were used to calculate effective dose in order to be able to compare CBCT
and FU CTA radiation dose. An anthropomorphic phantom was used as
comparison and a TG200 phantom enabled the direct comparison of the
accumulated radiation, without the need of conversion factors.
Results: Mean age was 73 years and average BMI was 27,5. CBCT
radiation contributed with a mean DAP of 66.0 Gycm22 (37,1 e94,4). The
3 phase FU CTA had a mean DLP of 948.7 mGycm (421 e1422). A CBCT of
5 seconds corresponded to one third of that of a 16 slice FU CTA. An 8
second spin was 87% of that of a 128 slice FU CTA. Accumulated radiation
from the CBCT ranged from 44% to 99% in comparison to the complete
FU CTA.
Conclusion: CBCT adds a considerably amount of radiation to the pa-
tient during an EVAR procedure. The comparison between CBCT and CT
depends on what type of CBCT protocol and how efﬁcient the CT scanner is.
This study showed that performing an intra-operative 8 second CBCT is
equivalent to a complete FU CTA, consisting of three CT scans. Further
optimization of CBCT protocol in regard of image quality and intra-opera-
tive results ought to be investigated.
Role of Hybrid Procedures in the Treatment of Iliac Femoral
Occlusive Disease
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Introduction: At aorta-iliac district for occlusive disease the ﬁrst choice
have became endovascular procedures because offer excellent results in
terms of patency, low mortality and morbidity rates. Stenosis/occlusion to
the femoral artery may reduce the patency and the technical success rate
of the endovascular procedures. In these cases a hybrid approach with
femoral endarterectomy and iliac stenting may be considered. We
